Robbins Farley’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-13,741
Closed -$988K 167
2023
Q1
$988K Sell
13,741
-21
-0.2% -$1.61K 0.66% 50
2022
Q4
$1.03M Sell
13,762
-14,216
-51% -$1.02M 0.79% 46
2022
Q3
$1.83M Sell
27,978
-632
-2% -$48.4K 1.5% 33
2022
Q2
$2.02M Buy
28,610
+259
+0.9% +$20.9K 2.1% 25
2022
Q1
$2.61M Sell
28,351
-472
-2% -$44.3K 1.96% 24
2021
Q4
$2.92M Buy
28,823
+605
+2% +$61.7K 2.16% 23
2021
Q3
$2.74M Buy
28,218
+1,839
+7% +$186K 2.02% 22
2021
Q2
$2.72M Buy
26,379
+792
+3% +$80.7K 3.07% 15
2021
Q1
$2.69M Buy
25,587
+55
+0.2% +$5.09K 2.37% 16
2020
Q4
$2.4M Buy
+25,532
New +$2.25M 2.37% 17

Other funds holding CRI

Robbins Farley's CRI Position: Q2 2023 in Review

Robbins Farley sold out of Carter's (CRI) in Q2 2023, closing a stake of 13,741 shares — an estimated $988K sold.

Robbins Farley first reported a position in CRI in Q4 2020 and held it in 10 quarters. The position peaked at $2.92M in Q4 2021. 292 funds tracked by Wall St. Rank hold CRI as of Q2 2023.

  • Robbins Farley reported no remaining Carter's position as of Q2 2023 after selling out during the quarter.
  • Robbins Farley sold 13,741 Carter's shares in Q2 2023, an estimated $988K.
  • Robbins Farley first reported a position in Carter's in Q4 2020 and held it in 10 quarters.
  • Robbins Farley's Carter's position peaked at $2.92M in Q4 2021.
  • 292 funds tracked by Wall St. Rank held Carter's as of Q2 2023.

Based on Robbins Farley's 13F filing for Q2 2023, filed 7 Aug 2023.